Asha Das

Center for Biologics Evaluation and Research

Also affiliated with United States Food and Drug Administration

ChemistryMedicineEnvironmental ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette–Guérin–Unresponsive Non–Muscle-Invasive Bladder Cancer”.

FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette–Guérin–Unresponsive Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2812

N/A

0DataRank · unranked

24 citations

Yuxia Jia, Anurag Sharma, Jiang Hu, Zhenzhen Xu, Daniel L. Suzman +5 more

FDA Approval Summary: Afamitresgene Autoleucel for Adults with HLA-Restricted, MAGE-A4–Positive Unresectable or Metastatic Synovial Sarcoma after Prior Chemotherapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0595

N/A

0DataRank · unranked

18 citations

Ann Johnson, Asha Das, Ching-Hsien J. Lee, Cong Wang, Xiaofei Wang +4 more

FDA Approval Summary: Lifileucel for Unresectable or Metastatic Melanoma Previously Treated with an Anti–PD-1–Based Immunotherapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0880

N/A

0DataRank · unranked

14 citations

Chaohong Fan, Peter Bross, Asha Das, Elin S. Cho, Karin M. Knudson +6 more